These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9624789)

  • 41. Stroke prevention therapies and management of patient subgroups.
    Raps EC; Galetta SL
    Neurology; 1995 Feb; 45(2 Suppl 1):S19-24. PubMed ID: 7885586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The European Stroke Prevention Study (ESPS): results by arterial distribution.
    Sivenius J; Riekkinen PJ; Smets P; Laakso M; Lowenthal A
    Ann Neurol; 1991 Jun; 29(6):596-600. PubMed ID: 1892362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Diener HC; Cunha L; Forbes C; Sivenius J; Smets P; Lowenthal A
    J Neurol Sci; 1996 Nov; 143(1-2):1-13. PubMed ID: 8981292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transient ischemic attacks and stroke.
    Mirsen TR; Hachinski VC
    CMAJ; 1988 Jun; 138(12):1099-105. PubMed ID: 3285985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of antiplatelet medication for prevention of myocardial infarction and stroke.
    Rakel RE
    Heart Dis Stroke; 1992; 1(1):2-3. PubMed ID: 1344081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A review of therapeutic strategies for risk reduction of recurrent stroke.
    Phillips RA
    Prog Cardiovasc Dis; 2008; 50(4):264-73. PubMed ID: 18156005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Secondary prevention of recurrent transient ischemic attacks].
    Pizzulli L; Lüderitz B
    Internist (Berl); 1998 Apr; 39(4):411-2. PubMed ID: 9599754
    [No Abstract]   [Full Text] [Related]  

  • 48. Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group.
    Sivenius J; Cunha L; Diener HC; Forbes C; Laakso M; Lowenthal A; Smets P; Riekkinen P
    Acta Neurol Scand; 1999 Jan; 99(1):54-60. PubMed ID: 9925239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Up to date review of the secondary preventive measures for recurrent ischaemic stroke and transient ischaemic episodes.
    Gibbs CR; Li-Saw-Hee FL; Lip GY
    Scott Med J; 1998 Feb; 43(1):6. PubMed ID: 9533251
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antithrombotic treatment as primary and secondary prevention of stroke].
    Chukanova EI; Chukanova AS; Nadareyshvili GG; Gulieva MS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):85-88. PubMed ID: 28635860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral antiplatelet therapy in stroke prevention. Minireview.
    Kral M; Herzig R; Sanak D; Skoloudik D; Vlachova I; Bartkova A; Hlustik P; Kovacik M; Kanovsky P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Sep; 154(3):203-10. PubMed ID: 21048805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [2nd European study on secondary prevention of stroke (ESPS 2). Respective roles of acetylsalicylic acid, dipyridamole and their combination].
    Franck G
    Rev Med Liege; 1995 Nov; 50(11):491. PubMed ID: 8532998
    [No Abstract]   [Full Text] [Related]  

  • 53. Update on antiplatelet therapy for stroke prevention.
    Sacco RL; Elkind MS
    Arch Intern Med; 2000 Jun; 160(11):1579-82. PubMed ID: 10847250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiplatelet therapy in the prevention of cardiovascular diseases.
    Mannucci PM; Cimminiello C; Cattaneo M
    Ann Ital Med Int; 1993; 8(3):189-94. PubMed ID: 8217485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?].
    Gorter JW; De Schryver EL; Algra A
    Ned Tijdschr Geneeskd; 1998 Feb; 142(6):316-8. PubMed ID: 9562733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of ischemic stroke after TIA: medical or surgical treatment? A review of the main trials.
    Annibali R; Pisacreta M
    Panminerva Med; 1989; 31(2):57-70. PubMed ID: 2677921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of a slower than standard dose escalation scheme for dipyridamole on headaches in secondary prevention therapy of strokes: a randomized, open-label trial (DOSE).
    de Vos-Koppelaar NC; Kerkhoff H; de Vogel EM; Zock E; Dieleman HG
    Cerebrovasc Dis; 2014; 37(4):285-9. PubMed ID: 24819911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [An acetylsalicylic acid-dypiridamole combination (Asasantine) in the prevention of the recurrence of cerebrovascular accidents (a cost-effectiveness analysis)].
    Kurz X; Annemans L; Dresse A
    Rev Med Liege; 1998 May; 53(5):265-9. PubMed ID: 9689880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prevention of stroke following transient cerebral ischemia: medical or surgical therapy? Review of the most important trials].
    Annibali R; Pisacreta M
    Minerva Chir; 1987 Nov; 42(22):1797-812. PubMed ID: 3323942
    [No Abstract]   [Full Text] [Related]  

  • 60. [Strategies for antiplatelet therapy-drug-fixed method and suppression-fixed method].
    Hattori A
    Nihon Rinsho; 1992 Feb; 50(2):385-91. PubMed ID: 1613995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.